6 Recruiting Primary Myelofibrosis Phase 2 Clinical Trials
Active phase 2 studies for primary myelofibrosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Primary Myelofibrosis studiesPhase 2 Studies for Primary Myelofibrosis
🔵 Active, Not Recruiting Phase2
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Study of Canakinumab in Patients With Myelofibrosis
📍 Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Decitabine in Treating Patients With Myelofibrosis
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
📍 GSK Investigational Site — Ann Arbor, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔